Baxter Worldwide Inc. (NYSE: BAX) on Thursday introduced monetary outcomes for the fourth quarter of 2024. The medical machine maker’s gross sales elevated modestly in the course of the quarter.
- Fourth-quarter gross sales from persevering with operations had been $2.75 billion, up 1% on a reported foundation and a pair of% on a relentless forex foundation
- US gross sales from persevering with operations in This fall totaled $1.51 billion, remaining flat on a reported foundation
- Worldwide gross sales from persevering with operations edged up 1% yearly $1.24 billion in the course of the three months
- Medical Merchandise & Therapies gross sales had been flat at reported charges and grew low single digits at fixed forex charges
- Pharmaceutical gross sales grew excessive single digits at each reported and fixed charges
- The corporate reported a web lack of $512 million or $1.00 per share for This fall, in comparison with web earnings of $245 million or $0.48 per share within the year-ago quarter
- Gross margin decreased 13% year-over-year to $959 million in This fall from $1.1 billion a 12 months earlier
- On an adjusted foundation, the corporate reported earnings of $0.77 per share for the December quarter, down 9% YoY
